LRCXLRCX
US • TECHNOLOGY
$305.21
P/E
57.61
PEG
1.41
FCF Yield
1.4%
Rev Growth YoY
+23.8% YoY
Gross Margin
50.0%
Health Score
9/10
D/E Ratio
0.45
Confidence
MEDIUM
Business Snapshot
Lam Research is a dominant player in the semiconductor equipment industry, specializing in wafer fabrication equipment and related services used in the production of integrated circuits. Its core revenue drivers are etch and deposition systems, critical technologies for advanced chip manufacturing at smaller nodes. Operating within a highly cyclical and capital-intensive market, Lam holds a leading competitive position alongside Applied Materials and Tokyo Electron, benefiting from secular trends in chip complexity and fabrication spending. As a large-cap company with a market capitalization of approximately $399.91 billion and trailing twelve-month revenue of $21.68 billion, it plays a central role in enabling the global semiconductor supply chain. The company is defined by its strong intellectual property moat and deep integration with its customers' manufacturing roadmaps.
Financial Health
Lam Research demonstrates robust financial health with a gross margin of 50.0% and an exceptional net margin of 30.9%, indicating strong pricing power and operational efficiency—though year-over-year margin trends are not available for comparison. The balance sheet is conservative, featuring a low debt-to-equity ratio of 0.45x and a healthy current ratio of 2.21x, providing ample liquidity...
Risk Assessment
- VALUATION — P/E of 57.61x is significantly above the sector average of 22x, making the stock vulnerable to multiple compression.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- 52-WEEK POSITION — The current price of $305.21 is well below the 52-week high of $438.50, reflecting a significant -30.4% decline from peak levels.
- INSIDER — Insider activity shows 0 buys versus 8 sells in the last 90 days, a bearish signal from those with the most knowledge of the company.
- VALUATION DIVERGENCE — The Python DCF estimate of $88.96 suggests significant overvaluation versus the current price of $305.21, creating a risk if fundamentals decelerate....
Lam Research demonstrates robust financial health with a gross margin of 50.0% and an exceptional net margin of 30.9%, indicating strong pricing power and operational efficiency—though year-over-year margin trends are not available for comparison. The balance sheet is conservative, featuring a low debt-to-equity ratio of 0.45x and a healthy current ratio of 2.21x, providing ample liquidity. Free cash flow stands at a strong $5.75 billion, yielding 1.4% relative to market cap, confirming the company is a significant cash generator. Overall, this combination of high margins, low leverage, and strong cash flow provides substantial financial flexibility for reinvestment in R&D, strategic acquisitions, or shareholder returns.
- VALUATION — P/E of 57.61x is significantly above the sector average of 22x, making the stock vulnerable to multiple compression. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - 52-WEEK POSITION — The current price of $305.21 is well below the 52-week high of $438.50, reflecting a significant -30.4% decline from peak levels. - INSIDER — Insider activity shows 0 buys versus 8 sells in the last 90 days, a bearish signal from those with the most knowledge of the company. - VALUATION DIVERGENCE — The Python DCF estimate of $88.96 suggests significant overvaluation versus the current price of $305.21, creating a risk if fundamentals decelerate.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives